ReviewPublic health weekly report2026
Lessons from Measles Elimination in the Republic of Korea: Public Health Implications.
Review in Public health weekly report, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Resilient public health in a changing world: as threats expand and prevention retreats.Osong public health and research perspectives · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To determine key policy implications, this study aims to examine the comprehensive national strategy implemented for measles elimination in 2001, the subsequent development of a public health system to sustain elimination, and its international verification. Methods: The author conducted a review of government-issued measles outbreak control guidelines from 2000 to 2001, domestic and international academic literature and theses, and materials from the World Health Organization (WHO) immunization-related meetings, including firsthand observations from participation in these meetings. Results: Following the Republic of Korea (ROK)'s introduction of a monovalent measles vaccine in 1965, the measles-mumps-rubella vaccine was incorporated into the National Immunization Program in 1983. In 1997, a second dose was added for children aged 4-6 years due to recurrent outbreaks; however, a large nationwide outbreak occurred in 2000-2001. Incidence was highest among infants aged 0-1 years and school-aged children, and was associated with by low second-dose coverage. Furthermore, serological surveys indicated that 13.5-15.5% of elementary school students were seronegative for measles antibodies, and viruses consistent with the H1 genotype were detected. In response to these findings, the government launched a 5-Year National Measles Elimination Plan, including school-based mass vaccination campaigns and pre-entry vaccination verification. This resulted in approximately 5.8 million children receiving two doses of measles-containing vaccine and strengthening surveillance. Consequently, measles was declared eliminated in 2006. In 2014, the ROK introduced fully subsidized National Immunization Program services, and the WHO Western Pacific Regional Verification Commission verified that the ROK had effectively eliminated measles. Since then, this elimination status has been maintained. Conclusions: The 2000-2001 measles epidemic in the ROK triggered a policy transformation that went beyond immediate outbreak control, fundamentally strengthening the public health system and positioning the country for greater engagement in global health collaboration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.